Gene Query: BTBD9

Dataset Description Geneva Score
Determination of tRNA aminoacylation levels by high throughput sequencing 129.76
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 65.1
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 57.27
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 53.76
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 47.91
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 47.42
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 40.26
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 39.83
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 38.92
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 38.77
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 37.87
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 37.79
MCF-7 as a model for functional analysis of breast cancer risk variants 34.58
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 33.8
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 33.15
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 32.83
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 32.42
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 32.22
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 31.27
STX4 Over-Expression in Human islets 30.25
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 29.62
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 29.62
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 28.91
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 28.62
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 26.95
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 26.95
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 26.83
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 24.81
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 24.59
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 24.47
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 23.84
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 23.58
Stem and effector CD8 T-cells from human cancers 23.42
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 23.32
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 23.28
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 23.14
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 22.82
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 21.75
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 20.82
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 20.53
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 20.24
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 20.14
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 19.75
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 19.69
FBXW7 modulates stress response by post-translational modification of HSF1 19.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 18.92
Single-Cell Genotyping of Transcriptomes 18.92
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 18.87
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 18.84
Single-cell analysis of human kidney organoids 18.84
Transcriptional profiling of LS1034 cells treated with tepoxalin 18.82
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 18.22
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 17.52
Effect of PRDM11 depletion in U2932 cells 16.95
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 16.67
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 16.52
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 16.48
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 16.03
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 15.96
Gene expression profiling of KSHV-infected periodontal ligament cells 15.83
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 15.79
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 15.66
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 15.59
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 15.53
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 15.18
The human blood-nerve barrier transcriptome 15.12
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 15.09
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 15.04
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 15.04
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 14.79
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 14.75
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 14.75
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 14.63
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 14.62
CD95/Fas ligand mRNA is toxic to cells 14.38
Reassessment of Exosome Composition 14.2
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 14.1
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 13.91
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 13.84
The role of m6A/m-RNA methylation in stress response regulation 13.84
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.79
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.79
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 13.46
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 13.31
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 13.31
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 13.23
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 12.94
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 12.94
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 12.88
Argonaute proteins couple chromatin silencing to alternative splicing 12.7
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 12.7
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 12.63
SNHG5 siRNA knock down in HCT116 cells 12.57
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 12.56
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 12.56
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 12.3
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 12.23
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 12.23
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 12.0
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 11.92
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 11.7
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 11.59
Identification of Atrial Fibrillation associated genes and functional non-coding variants 11.52
Effect of Hotair overexpression in human breast cancer cell lines 11.18
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 11.14
RNA-sequencing 10.66
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 10.54
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 10.49
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 10.15
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.12
U1 snRNP telescripting regulates size-function stratified human genome 10.12
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.05
Zika virus directly infects human peripheral neurons and induces cell death 9.92
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 9.75
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.61
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 9.58
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 9.49
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.42
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 9.38
Transcriptome analysis upon C6orf203 silencing 9.35
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.31
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 9.23
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 9.22
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 9.15
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 8.96
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 8.94
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 8.81
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.56
The evolution of N6-methyladenosine in primates 8.47
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.42
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.42
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  8.4
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.39
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.29
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.22
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 8.22
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.19
The comparison of high-throughput single-cell RNA-seq methods 8.17
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.13
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 8.06
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 7.95
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 7.95
Landscape of H3K4me3 in human CD19 cells 7.9
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 7.83
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.8
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 7.79
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 7.79
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.74
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.74
Modeling Familial Cancer with iPSC Approaches 7.72
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.64
The transcriptome and chromatin accessbility landscape of mammalian germline 7.53
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 7.5
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.5
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 7.48
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 7.47
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.42
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 7.36
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 7.31
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 7.27
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.25
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 7.24
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 7.24
Transcriptome analysis in Neobractatin treated cells 7.23
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.18
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 7.17
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.11
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.11
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.08
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 7.02
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 7.02
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.96
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.9
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.88
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.83
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 6.78
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 6.78
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.76
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 6.73
Differential Protein Occupancy Profiling of the mRNA Transcriptome 6.67
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.65
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.63
DART-seq: an antibody-free method for global m6A detection 6.58
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.57
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.57
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.47
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 6.45
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.39
EP400 is required for Max and MCPyV mediated gene activation 6.38
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 6.34
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.3
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.3
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 6.03
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 6.0
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 5.96
Transcriptome-wide response to synthetic chromatin protein PcTF 5.94
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 5.94
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 5.91
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 5.91
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.89
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.87
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.87
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 5.82
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.8
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.79
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 5.75
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 5.72
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 5.64
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 5.63
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.59
RNA polymerase in pre-B-ALL cell lines 5.48
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 5.39
4sU-seq of HFF exposed to salt and heat stress 5.36
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.31
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.31
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.28
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.23
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 5.2
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.11
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.09
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.09
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 5.0
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 4.98
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.96
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.96
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 4.94
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.87
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.84
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 4.8
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 4.77
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.75
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.74
Trans-differentiation of human adult peripheral blood T cells into neurons 4.73
MAIT cell RNA sequencing 4.72
4.71
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.7
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.65
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.64
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.63
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 4.62
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 4.62
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.59
Landscape and variation of RNA secondary structure across the human transcriptome 4.56
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 4.51
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 4.5
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.5
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.48
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.44
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.44
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 4.43
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.42
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.42
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.37
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.36
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.35
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.35
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.34
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.34
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.32
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 4.31
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.22
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 4.22
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 4.22
Role of microRNAs in the interaction between Salmonella and the host cell 4.19
Exploring the RNA landscape of endothelial exosomes 4.18
Global expression profiles in cardiac progenitor cells generated by ISX-9 4.17
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 4.17
Single-cell analysis of adult human ovary using 10X genomics 4.15
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 4.11
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.09
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.06
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.06
BCL11B 4.05
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.04
Role of COP1 on MAP kinase transcriptional output in melanoma 4.04
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 4.02
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 3.98
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 3.97
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 3.97
A prostate cancer chromatin interaction map 3.93
RNA-seq melanoma 3.92
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 3.87
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 3.86
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.82
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.81
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.79
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.79
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.79
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.78
HEK293 Heat-shock experiment 3.75
H1609088 Human RNA-Sequencing 3.72
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.7
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.7
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.69
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.68
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.67
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 3.6
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.58
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 3.53
Transcriptomes in healthy and CHB fetal hearts 3.53
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 3.52
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.52
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.49
METTL3 and WTAP 3.47
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.47
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.47
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.41
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.35
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.35
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 3.34
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 3.34
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.34
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 3.33
Real-time observation of light-controlled transcription in living cells 3.31
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.26
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.23
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  3.23
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.22
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.21
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.2
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.15
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.14
Reprogrammed myeloid cell transcriptomes in NSCLC 3.14
Genome-wide mapping of TEL-AML1 targets in acute leukemia 3.13
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 3.09
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 3.09
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.04
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.01
Dermal endothelial cells of type 2 diabetic patients 3.0
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.99
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 2.98
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.95
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.92
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 2.92
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 2.92
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.91
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.91
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.91
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 2.91
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 2.91
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.9
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 2.85
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.83
Modeling Human Cancer-induced Cachexia (Human) 2.83
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.82
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.82
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.79
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.75
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.72
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.7
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.66
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.64
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.64
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 2.55
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 2.53
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.48
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.48
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.47
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 2.42
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.38
Regulation of highly expressed hCINAP on translatome 2.36
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 2.35
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.34
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.33
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.33
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.25
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.23
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.23
Gene expression analysis of human hepatocellular cancers 2.22
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 2.14
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.07
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 2.0
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.99
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.98
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.97
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.97
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.95
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.92
Gene expression activation in CLL mediated by MSCs contact 1.83
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.83
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.82
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.81
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.81
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.78
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.75
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.74
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.74
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 1.7
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.7
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.68
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.6
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.59
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.58
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.57
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.56
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 1.55
RNA-seq of human aneuploid cell lines with Trisomy 21 1.54
Role of cervicovaginal microbiota in genital inflammation 1.52
Discovering human diabetes-risk gene function with genetics and physiological assays 1.48
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.4
Derivation and differentiation of haploid human embryonic stem cells 1.38
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.37
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.37
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.35
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.34
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.33
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.31
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.31
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.23
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.23
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.21
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.21
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 1.2
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.19
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.19
SLAM-seq for K562 endogenous mRNA decay 1.19
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 1.13
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.13
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.12
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.12
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.06
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.06
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.04
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.04
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.03
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.02
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.98
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.98
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.98
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.98
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.98
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.98
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.97
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.97
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.95
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.94
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.94
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 0.93
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.93
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.9
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.88
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.87
Characterization of the Merkel cell carcinoma miRNome 0.86
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 0.81
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.8
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.79
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 0.79
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.79
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.79
The pioneer factor CEBPA modulates vitamin D signaling 0.77
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.77
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.75
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.72
Gene expression changes caused by KRAS in MCF-10A 0.7
Global transcriptome analysis of HAP1 cells 0.69
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.68
Toxoplasma gondii infection of human retinal pigment epithelial cells 0.67
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.66
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.61
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.6
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 0.6
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 0.58
Interphase condensins regulate ligand-depedent enhancer activation 0.57
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.57
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.56
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.53
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.52
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.5
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.49
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.47
Gene expression analysis of the impact of TDP-43 knockout in human cells. 0.47
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.44
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 0.43
Fibroblasts in cholesteatoma activate osteoclasts. 0.43
The transcriptome of Kawasaki Disease arteritis 0.42
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.42
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.41
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.39
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.39
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.39
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.38
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.38
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 0.36
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.35
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.35
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.3
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.27
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.22
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.22
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.19
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 0.18
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 0.18
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.11
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.1
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.1
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.09
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.09
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation